European Heart Journal

Half-dose rivaroxaban vs antiplatelet therapy for preventing silent cerebral embolism after left atrial appendage occlusion: the HALO-SCE trial

By Kexin Wang, Linsheng Shi, Zhongbao Ruan, Weizhu Ju

Randomised trial in 164 peopleInterventions

365 days, multicentre

The paper

Kexin Wang, Linsheng Shi, Zhongbao Ruan, Weizhu Ju

Jiangsu Province Hospital

European Heart Journal, 31 Aug 2026

doi.org/10.1093/eurheartj/ehag734 PubMed 42670954

Frontiers in Aging Neuroscience8 Oct 2026
More daily steps modestly improved one thinking test score
Research Square4 Oct 2026
Cognitive training improves MoCA scores in older adults with MCI
medRxiv4 Oct 2026
Brain MRI predicts conversion to mild cognitive impairment
Neurology4 Oct 2026
Early ablation is linked to lower cardiovascular risk after stroke